CVM

Conviction 0HealthcareScan · Thu, Jun 25, 2026

CVM$0.9745-2.06%

ResistanceSupportVol 14Insider buy

Vol MA14 445.97K

Mar 26Apr 14May 1May 19Jun 8Jun 25

CEL SCI CORPBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.cel-sci.com ↗

Price0.9745

Change-2.06%

Gap+0.50%

Rel volume0.74×

Avg volume365.58K

Avg $ vol419.24K

SMA 201.23

SMA 501.92

SMA 2005.18

Price vs 50-49.26%

Price vs 200-81.17%

MA stackbearish

50/200 cross—

Supertrenddown · 1.36

RSI (14)29

MACD hist0.03

MACD cross—

Stoch %K / %D3 / 2

ADX (14)30

+DI / −DI19 / 27

RSI divergence—

MACD divergence—

ATR %+15.45%

ADR %9.19%

52w high13.04

52w low0.9745

From 52w high-92.53%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width68.67%

%B0.20

Donchian pos2.29%

Donchian high1.59

Donchian low0.9601

AVWAP (52w high)3.79

vs AVWAP high-74.26%

AVWAP (52w low)1.26

vs AVWAP low-22.68%

OBV trendDown

Chaikin MF (20)-0.38

Today vs 20d0.74×

Avg vol (14d)445.97K

Avg vol (20d)365.58K

Avg $ vol (20d)419.24K

Market cap8.28M

RS 3m (vs SPY)-83.16%

RS 6m (vs SPY)-87.47%

RS line new highNo

Trend template0/8

Technical rank2.9

1 week-11.41%

1 month-31.85%

3 months-72.39%

6 months-78.54%

1 year-59.90%

YTD-81.08%

P/E-0.33

P/B1.20

P/S31.35

P/FCF-0.48

EPS-6.27

Div yield—

ROE-369.63%

ROA-143.51%

Debt/Eq—

Current0.60

EV/EBITDA-0.14

Gross margin—

Net margin—

Rev growth65.45%

EPS growth5.61%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value3.14M

Revenue77.4K

Net income-5.47M

Gross profit—

Free cash flow-17.16M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNYSE

Shares out8.49M

Employees44

ListedThu, Dec 8, 1983

Free float8.12M

Float %96.0%

Short interest230.68K

Days to cover0.5d

Short volume50.3%

Squeeze score15 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank2.9 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.73

Support0.9425

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CVM

All disclosures →

No recent disclosed trades by Congress in CVM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CVM · 2 buys

Insider	Side	Shares	Value	Traded	Filed
KERSTEN GEERT R Chief Executive Officer · Common Stock · 2026-05-14	Buy	300K	$360K	2026-05-14	2026-05-18
KERSTEN GEERT R Chief Executive Officer · Common Stock · 2026-05-14	Other	—	—	2026-05-14	2026-05-18
KERSTEN GEERT R Chief Executive Officer · Common Stock · 2026-05-13	Buy	100K	$119K	2026-05-13	2026-05-14

SEC filings

EDGAR filings in CVM · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.